Skip to main content

Royalty Pharma plc

RPRXNASDAQ
$56.66-0.50 (-0.87% today)
Legend
Insider buy
Insider sell
Congress buy
Congress sell
Hedge Funds
bought vs sold
Greener markers show more buyers; redder markers show more sellers.
Company share activityNet buybacksNo changeNet dilution
Marker size reflects transaction size.
  • Insider buy
  • Insider sell
  • Congress buy
  • Congress sell
  • Hedge Funds bought vs sold
Share activityNet buybacksNo changeNet dilution

Marker size reflects transaction size. Greener fund markers mean more buyers.

  • Insider Buy
  • Insider Sell
  • Congress Buy
  • Congress Sell
  • Hedge funds bought vs sold
  • BuybackNo changeNet dilution

Royalty Pharma plc price and activity chart data

Showing the 1Y range: Oct 6, 2025 to Oct 5, 2026. Price (+56.8%). 0 insider or congressional trades plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding

Largest institutional holders

13F · Q2 2026
Fund% of company heldValue% of portfolioQuarterly activity
Morgan Stanley11.06%$2.41B0.13%Not reported
Capital International Investors9.09%$1.98B0.41%Add 0.77%
BlackRock, Inc.7.17%$1.56B0.02%Not reported
FMR LLC6.32%$1.37B0.06%Not reported
State Street Corp3.18%$692M0.02%Not reported
Swedbank AB2.76%$601M0.52%Reduce 7.42%
Baillie Gifford & Co2.58%$562M0.51%Reduce 38.01%
Capital World Investors2.45%$534M0.06%Add 18.42%
Geode Capital Management, LLC2.08%$451M0.02%Not reported
Caledonia (Private) Investments Pty Ltd1.49%$324M11.06%Reduce 19.43%
Norges Bank1.37%$299M0.03%Not reported
Vanguard Capital Management LLC1.24%$271M0.01%Not reported
Northern Trust Corp1.22%$265M0.03%Not reported
Royal London Asset Management Ltd1.11%$242M0.45%Add 13.42%
AQR Capital Management LLC1.11%$241M0.08%Not reported
Invesco Ltd.1.09%$237M0.02%Not reported
Bank of America Corp1.07%$233M0.02%Not reported
Legal & General Group Plc0.98%$213M0.04%Not reported
Amundi0.96%$209M0.05%Not reported
Victory Capital Management Inc0.95%$207M0.12%Not reported
Patient Capital Management, LLC0.93%$202M6.61%Reduce 1.23%
UBS Group AG0.81%$176M0.02%Not reported
Charles Schwab Investment Management Inc0.79%$173M0.02%Not reported
Two Sigma Investments, LP0.75%$164M0.12%Not reported
Deutsche Bank Ag\0.70%$152M0.04%Not reported
Nordea Investment Management AB0.66%$146M0.12%Add 226.99%
Adage Capital Partners GP, L.L.C.0.64%$140M0.20%Reduce 66.58%
Vanguard Portfolio Management LLC0.63%$138M0.01%Not reported
Dorsey Asset Management, LLC0.63%$138M8.82%Add 7.90%
Marshall Wace, LLP0.63%$137M0.11%Not reported
Regal Partners Ltd0.63%$137M7.58%Reduce 6.73%
Arrowstreet Capital, Limited Partnership0.63%$137M0.06%Not reported
Goldman Sachs Group Inc0.62%$135M0.01%Not reported
New South Capital Management Inc0.61%$134M5.87%Reduce 9.14%
Vanguard Fiduciary Trust Co0.56%$121M0.03%Not reported
Renaissance Technologies LLC0.50%$109M0.15%Not reported
JPMorgan Chase & Co0.45%$100M0.01%Not reported
Russell Investments Group, Ltd.0.44%$95.6M0.08%Not reported
Clark Capital Management Group, Inc.0.43%$93.2M0.51%Add 1.40%
Homestead Advisers Corp0.43%$92.9M2.31%Add 0.25%
Raymond James Financial Inc0.41%$89.7M0.02%Not reported
Qube Research & Technologies Ltd0.36%$79.2M0.07%Not reported
Eventide Asset Management, LLC0.36%$77.7M1.04%Add 5.16%
Citadel Advisors LLC0.35%$76M0.01%Not reported
Mitsubishi UFJ Trust & Banking Corp0.34%$73.3M0.16%Reduce 12.51%
Bank of New York Mellon Corp0.33%$71.1M0.01%Not reported
BNP PARIBAS ASSET MANAGEMENT Holding S.A.0.31%$67.6M0.07%Add 2.20%
Sumitomo Mitsui Trust Group, Inc.0.31%$66.6M0.04%Reduce 6.73%
Swiss National Bank0.30%$65M0.03%Not reported
Nuveen, LLC0.30%$64.9M0.02%Not reported
50 of 600 holders

Activity score

Premium
0
25
50
75
100
WEAK
STRONG
Unlock

AI Activity Analysis

Premium
Coming soonAI reads of insider, institutional and company activity will appear here for Premium accounts.

Historical Activity Patterns

Premium
Historical Activity PatternsHistorical periods where multiple activity categories converged, with subsequent market performance shown for context.Unlock

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.